$111 Million is the total value of BML Capital Management, LLC's 31 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BIL | SPDR SER TRbloomberg 1-3 mo | $18,364,000 | 0.0% | 200,000 | 0.0% | 16.52% | +4.1% | |
ATHA | ATHIRA PHARMA INC | $5,501,476 | +18.0% | 1,864,907 | 0.0% | 4.95% | +22.8% | |
ASTROTECH CORP | $3,121,006 | +32.8% | 220,410 | 0.0% | 2.81% | +38.2% | ||
FBRX | FORTE BIOSCIENCES INC | $1,804,478 | +3.0% | 1,735,075 | 0.0% | 1.62% | +7.1% | |
ABIO | ARCA BIOPHARMA INC | $1,435,068 | +2.0% | 706,930 | 0.0% | 1.29% | +6.2% | |
LISATA THERAPEUTICS INC | $902,204 | +14.0% | 243,839 | 0.0% | 0.81% | +18.7% | ||
VRCA | VERRICA PHARMACEUTICALS INC | $865,500 | -11.2% | 150,000 | 0.0% | 0.78% | -7.6% | |
RVP | RETRACTABLE TECHNOLOGIES INC | $768,861 | -34.3% | 668,575 | 0.0% | 0.69% | -31.6% | |
NXTC | NEXTCURE INC | $551,637 | +21.6% | 306,465 | 0.0% | 0.50% | +26.5% | |
GRPH | GRAPHITE BIO INC | $395,957 | +6.1% | 152,291 | 0.0% | 0.36% | +10.2% | |
NLTX | NEOLEUKIN THERAPEUTICS INC | $19,712 | +18.6% | 23,749 | 0.0% | 0.02% | +28.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-07-24
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR SER TR | 7 | Q2 2024 | 16.9% |
ATHIRA PHARMA INC | 7 | Q2 2024 | 4.9% |
ASTROTECH CORP | 7 | Q2 2024 | 2.8% |
FORTE BIOSCIENCES INC | 7 | Q2 2024 | 1.6% |
VERRICA PHARMACEUTICALS INC | 7 | Q2 2024 | 2.9% |
MILESTONE PHARMACEUTICALS IN | 7 | Q2 2024 | 1.0% |
LISATA THERAPEUTICS INC | 7 | Q2 2024 | 0.8% |
ISHARES TR | 6 | Q2 2024 | 25.0% |
ELIEM THERAPEUTICS INC | 6 | Q1 2024 | 6.4% |
ORAMED PHARMACEUTICALS INC | 6 | Q2 2024 | 2.7% |
View BML Capital Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-07 |
N-PX | 2024-08-07 |
13F-HR/A | 2024-04-24 |
13F-HR | 2024-04-23 |
13F-HR/A | 2024-02-02 |
13F-HR | 2024-01-30 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-24 |
13F-HR | 2023-04-14 |
13F-HR | 2023-02-13 |
View BML Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.